Latest Conference Articles

November 25th 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

November 24th 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

November 23rd 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

Watch Dr. Aditya Bardia, Dr. Seth A. Wander and Dr. Laura M. Spring answer questions about HR-positive disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

November 22nd 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

Watch Dr. Laura M. Spring, from Massachusetts General Hospital in Boston, discuss treatment in third line and beyond for hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

November 21st 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

Watch Dr. Seth A. Wander, from Massachusetts General Hospital in Boston, discuss the first- and second-line treatment of hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

October 24th 2022, 7:00pm

An expert recommends that cancer survivors and patients take several actionable steps to improve their quality of sleep.

October 22nd 2022, 2:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. Hossein Borghaei, Dr. Jessica R. Bauman and Dr. Devika Das answer questions about supportive care during the CURE Educated Patient Lung Cancer Summit.

October 21st 2022, 1:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. Devika Das, from University of Alabama at Birmingham Medicine, discuss the benefits of telemedicine in cancer care during the CURE® Educated Patient® Lung Cancer Summit.

October 20th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. Jessica R. Bauman, from Fox Chase Cancer Center, discuss palliative care during the CURE Educated Patient Lung Cancer Summit.

October 19th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. Hossein Borghaei, Dr. David Gerber, Dr. Aaron S. Mansfield and Dana M. Haagen answer questions on the management of advanced/metastatic disease during the CURE Educated Patient Lung Cancer Summit.

October 18th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dana Haagen, from Fox Chase Cancer Center, discuss clinical trials and how patients can join them, during the CURE® Educated Patient® Lung Cancer Summit.

October 17th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. Aaron S. Mansfield, from Mayo Clinic, discuss the management of mesothelioma during the CURE Educated Patient Lung Cancer Summit.

October 16th 2022, 2:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. David Gerber, from UT Southwestern Medical Center, discuss antibody drug conjugates during the CURE Educated Patient Lung Cancer Summit.

October 15th 2022, 2:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. Hossein Borghaei, Dr. Jared Weiss and Dr. Anne Chiang answer questions about early disease management during the CURE Educated Patient Lung Cancer Summit.

October 14th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. Anne Chiang, from Yale School of Medicine, discuss molecular testing and adjuvant targeted therapies during the CURE Educated Patient Lung Cancer Summit.

October 13th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: October 1, 2022

Watch Dr. Jared Weiss, from UNC School of Medicine, discuss neoadjuvant versus adjuvant therapy during the CURE Educated Patient Lung Cancer Summit.

September 14th 2022, 7:00pm

Lumakras outperformed chemotherapy in reducing the risk of progression or death and improving quality of life for patients with KRAS G12C-mutated non-small cell lung cancer, study results showed.

September 14th 2022, 3:00pm

ESMO

None of the more than 100 evaluable patients with mismatch repair deficient colon cancer have experienced disease recurrence after treatment with presurgical Opdivo plus Yervoy, according to study results.

September 14th 2022, 1:00pm

Treatment with Libtayo may improve survival over a 30-month period with no new side effects in patients with recurrent or metastatic cervical cancer, opening the doors for an immunotherapy option for these patients.

September 13th 2022, 7:00pm

Two years of the hormone treatment androgen-deprivation therapy (ADT) after radiotherapy and radical prostatectomy tended to improve metastasis-free survival for patients with prostate cancer, study results showed.

September 13th 2022, 1:12pm

ESMO

The use of a tumor-infiltrating lymphocyte therapy led to better outcomes than treatment with Yervoy in patients with unresectable, treatment-refractory stage 3/4 melanoma, a type of skin cancer, study results showed.

September 12th 2022, 7:04pm

With nearly one-year of additional follow-up, adding Keytruda to the combination of abiraterone acetate and the steroid prednisone shows continued benefit in men with metastatic castration-resistant prostate cancer.

September 12th 2022, 3:00pm

The addition of Cabometyx to the current standard-of-care frontline regimen of Opdivo plus Yervoy improved progression-free survival outcomes in patients with advanced kidney cancer.

September 12th 2022, 1:04pm

Lenvima plus Keytruda improved survival outcomes for patients with pretreated advanced endometrial cancer, according to recent clinical trial data.

September 9th 2022, 9:00pm

Adding the novel drug oleclumab to Imfinzi and chemotherapy for the frontline treatment of advanced triple-negative breast cancer did not improve clinical outcomes, according to recent study findings.

September 9th 2022, 7:00pm

Rubraca improved progression-free survival in patients with BRCA1/2-mutant, platinum-sensitive, relapsed ovarian cancer, according to findings from the ARIEL4 clinical trial.

July 29th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: June 25, 2022

Watch Dr. Ravi Salgia, Dr. Erminia Massarelli, Dr. Jyoti Malhotra and Daniel Saez answer questions about advancements in lung cancer during the CURE Educated Patient Lung Cancer Summit.

July 28th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: June 25, 2022

Watch Dr. Jyoti Malhotra, from City of Hope, discuss advancements in advanced-stage non-small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

July 27th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: June 25, 2022

Watch Dr. Erminia Massarelli, from City of Hope, discuss advancements in early-stage non-small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

July 26th 2022, 1:00pm

Educated Patient® Lung Cancer Summit: June 25, 2022

Watch Dr. Ravi Salgia, from City of Hope, discuss advancements in small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.